ABOUT THE PRODUCT
HERCESSI™ is a trastuzumab-strf biosimilar, now preferred under Express Scripts and Cigna Healthcare formularies, offering patients a reliable and affordable treatment option for HER2-positive cancers.
Information is owner-confirmed
Last updated 2 months ago
Price range
Other products/services from Accord BioPharma
CAMCEVI® (filgrastim-laha)
Pharmaceutical
N/A
Accord BioPharma
United States (US)